Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries ...
12d
GlobalData on MSNSanofi moves closer to selling controlling stake in $17bn-valued OpellaSanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.
Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...
Sanofi Consumer Healthcare India has reported 1% rise in net profit to Rs 46.35 crore on a 6.8% increase in net sales to Rs 170.70 crore in Q3 FY25 as compared with Q3 FY24.
It sells products through independent distributors primarily in India.Sanofi Indias products viz. Lantus, Combiflam, Amaryl and Allegra feature in the top 100 pharmaceutical brands in India.
In its third-quarter results update, Sanofi said the consumer health unit – which owns brands like allergy therapies Allegra and Xyzal, irritable bowel syndrome product Buscopan, painkiller ...
Opella also based in France which is partially owned by Sanofi and focuses on consumer self-care with well-known over-the-counter brands like Allegra and Dulcolax. Finally, we also won one of the ...
While Allegra offers relief to users ... Because very few people are aware that early T1D screening exists, Sanofi and Ruder Finn created the Screen For Type 1 campaign. The year-long initiative urged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results